Antimicrobial drug resistance (AMR)

AMR is said to be the ability of a microbe to withstand the effects of medication that once might successfully treat the microbe. The word antibiotic resistance (AR or ABR) is a detachment of AMR, as it relates only to the bacteria becoming resistant to antibiotics. Resistant microbes are more problematic to treat, requiring alternative medications or higher doses of antimicrobials. These methodologies may be more expensive, higher toxicity risk or both. Microbes resistant to numerous antimicrobials are called multidrug resistant (MDR). The classes of drug resistance are extensively drug-resistant (XDR) and totally drug- resistant (TDR).

 

  • Mechanism of bacteria exhibiting drug resistance
  • Heteroresistance in multidrug-resistant Gram-negative pathogens
  • Drug resistant monitoring programs(MRSA,VRSA,ESBL,VRA,MRAB)
  • Bacterial strain - Superbugs
  • Global action plan and awareness
  • Cause and Control

Related Conference of Antimicrobial drug resistance (AMR)

March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands

Antimicrobial drug resistance (AMR) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in